Key studies defining the DNA alkylation properties and selectivity of a new class of exceptionally potent, naturally occurring antitumor antibiotics including CC-1065, duocarmycin A, and duocarmycin SA are reviewed. Recent studies conducted with synthetic agents containing deep-seated structural changes and the unnatural enantiomers of the natural products and related analogs have defined the structural basis for the sequence-selective alkylation of duplex DNA and fundamental relationships between chemical structure, functional reactivity, and biological properties. The agents undergo a reversible, stereoelectronicaily controlled adenine-N3
within the narrower, deeper AT-rich minor groove and the steric accessibility to the alkylation site that accompanies deep ATrich minor groove penetration control the sequence-selective DNA alkylation reaction and stabilize the resulting adduct. For the agents that possess sufficient reactivity to alkylate DNA, a direct relationship between chemical or functional stability and biological potency has been defined.
Substantial progress has been made in understanding the fundamental principles responsible for the sequence-selective recognition of DNA by small organic molecules (1-4) including a range of naturally occurring antitumor antibiotics. Three fundamental issues that arise in the examination of DNA binding agents are the origin of binding affinity, binding selectivity, and reaction selectivity including DNA alkylation or cleavage. Each can independently assert levels of control on the sequence-selective recognition of DNA and the relative role and origin of these effects remain a primary objective of most investigations. The emergence of experimental techniques for the rapid sequencing of DNA (5) (6) (7) (8) (9) , for the determination of DNA binding selectivity and affinity including footprinting and affinity cleavage techniques (10, 11) , and for the determination of sites of DNA modification (12) coupled with the rapid advances made in the structural characterization of DNA complexes at defined sites by x-ray crystallography (13, 14) , NMR spectroscopy (15, 16) , and molecular modeling (17, 18) have advanced the understanding of the molecular interactions responsible for the sequence-selective recognition of DNA. A powerful complement to such tools in the examination of naturally derived DNA binding agents is the preparation and subsequent examination of key partial structures, agents containing deepseated structural modifications or variations in the natural product and their corresponding unnatural enantiomers. Deliberate, well-conceived deep-seated modifications may directly address and define both the structural basis for the sequence selective recognition of DNA and fundamental relationships between structure, functional reactivity, and biological properties.
CC-1065 and the Duocarmycins. One of the newest class of agents shown to alkylate DNA includes (+)-CC-1065 (1; ref. 19 ), (+)-duocarmycin A (2; refs. [20] [21] [22] [23] [24] , and (+)-duocarmycin SA (3; refs. 25 and 26) . Given their remarkable cytotoxic potency, substantial efforts have been devoted to defining their properties (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) . In these studies, the agents have been shown to exert their biological effects through a sequence-selective alkylation of DNA. The reversible, stereoelectronically controlled adenine-N3 addition to the least substituted cyclopropane carbon has been found to occur within selected ATrich sites in the minor groove and extensive efforts have been devoted to determine the origin of the DNA alkylation selectivity, to establish the link between DNA alkylation and the ensuing biological properties (40) , and to define the fundamental principles underlying the relationships between structure, chemical reactivity, and biological activity. The limited studies conducted with naturally derived duocarmycin SA (3) revealed a combination of properties that make it the most exciting of the natural products identified to date. In addition to lacking the delayed toxicity characteristic of (+)-CC-1065 (41) , it is the most stable and most potent member of this class of agents. As detailed herein, it is likely that this combination of properties is not fortuitous but rather that the enhanced functional stability of 3 is directly responsible for its increased biological potency.
2, Duocarmycin A 3, Duocarmycin SA DNA Alkylation Selectivity. The event, sequence selectivity, quantitation, reversibility, and structure determination of the predominant DNA alkylation reaction by 1-3 have been defined (42) (43) (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) . The alkylation site identification and the assessment of relative selectivity were derived through thermally induced depurination and strand cleavage of labeled DNA after exposure to the agents (Scheme I). The alkylation selectivity for (+)-duocarmycin A (2) and (+)-duocarmycin SA (3) proved nearly indistinguishable (43, 45) . Each alkylation site detected was adenine flanked by two 5' A or T bases and there proved to be a preference for this three-base sequence: 5'-AAA > 5'-TTA > 5'-TAA > 5'-ATA. In addition, a strong preference for the fourth 5' base to be A or T versus G or C was observed and distinguishes the high-versus low-affinity sites. Table 1 summarizes the consensus sequence de-*To whom reprint requests should be addressed. (43, 45) .
The study of (+)-CC-1065 revealed a similar, but more extended, 5-bp AT-rich alkylation selectivity (42, (53) (54) (55) (56) (57) (58) (59) (42, 58) .
Unnatural Enantiomer DNA Alkylation Selectivity. One of the more revealing discoveries made possible through use of synthetic materials was that the unnatural enantiomers also constitute effective DNA alkylating agents (42, 43, 56, 58) . ent-(-)-Duocarmycin SA (3) was found to alkylate DNA but at concentrations -1OX that required for the natural enantiomer (43) and Table 1 summarizes its consensus alkylation sequence. Each alkylation site detected was adenine and essentially each alkylation site was flanked by a 5' and 3' A or T base that exhibited the following sequence preference: 5'-AAA > 5'-AAT > 5'-TAA > 5'-TAT. An additional strong preference for the second 3' base from the alkylation site to be A or T was observed. In this regard, the ent-(-)-duocarmycin SA alkylation proved analogous to the natural enantiomer with the exception that the binding orientation is reversed (5' -> 3') over an AT-rich 3.5-bp site. However, while the bound conformation of the natural enantiomer covers an AT-rich 3.5-bp site extending from the adenine-N3 alkylation site in the 3' -> 5' direction across the adjacent 2-3 5' bases (i.e., 5'-AAAA), the AT-rich 3.5-bp site for the unnatural enantiomer extends in the reverse 5' -> 3' direction starting at the first 5' base site preceding the adenine-N3 alkylation site and extending across the alkylation site to the first and second adjacent 3' bases (i.e., 5'-AAAA). The reversed binding orientation is required to permit adenine alkylation at the least substituted cyclopropane carbon and the offset AT-rich alkylation selectivity is the natural consequence of the diastereomeric relationship of the adducts. Similarly, ent-(-)-CC-1065 was found to alkylate DNA with a rate and efficiency that were comparable to the natural enantiomer (56) . Table 1 summarizes the consensus alkylation sequence for ent-(-)-CC-1065, which proved similar to ent-(-)-duocarmycin SA but which exhibits an extended 5-bp AT-rich selectivity (42, 56) . Each alkylation site proved consistent with 5' adenine-N3 alkylation with agent binding in the minor groove in the 5' ->3' direction from the alkylation site covering 5 bp across an AT-rich region. All alkylation sites detected proved to be adenine and nearly all of the 3' and 5' bases flanking the adenine-N3 alkylation site proved to be A or T. Like the natural enantiomer, there proved to be a preference for this sequence that follows the order 5'-AAA > 5'-TAA > 5'-AAT, 5'-TAT. There also proved to be a substantial preference for the second and third 3' base to be A or T.
Adenine-N3 Alkylation. The quantitation of the adenine-N3 alkylation, confirmation of its structure through isolation and characterization of the thermally released adducts, and the search for unde- tPercentage composition within the DNA examined. (50) , within oligodeoxynucleotides lacking a high-affinity adenine-N3 alkylation site (51) , or when the adenine alkylation sites within AT-rich regions of DNA were protected from alkylation with high-6, Duocarmycin B1: X = Br 7, Duocarmycin Ci: X= Cl affinity AT-rich minor groove binding agents (52) . In contrast, duocarmycin SA (3) showed no evidence of guanine-N3 alkylation when subjected to similar or more forcing conditions (43 consequence of the diastereomeric relationship of the adducts and the reversed binding orientation in the minor groove with respect to the alkylation site is required to permit adenine-N3 addition to the least substituted carbon of the electrophilic cyclopropane. The importance of the fourth base (A/T > G/C) in the binding sequences is the reason this site constitutes a high-affinity site for the unnatural enantiomer but only a minor site for the natural enantiomer. Similarly, the CC-1065 models (42) accommodate the more extended 5-bp AT-rich binding site size and alkylation selectivity of the enantiomeric agents, their reversed binding orientation in the minor groove, and their offset AT-rich selectivity relative to the alkylation site.
The apparently confusing distinctions in the relative efficiency of the natural versus unnatural enantiomer DNA alkylation reactions were found to correlate with the inherent steric bulk surrounding the agent C7 center for which the unnatural enantiomers are especially sensitive, consistent with expectations based on the models (42, 43, 60 The accuracy of the models was revealed when they were found to provide a beautiful explanation for the unusual observation that both enantiomers of simple derivatives of the alkylation subunit-i.e., N-Boc-DSA (11; ref. 43) or N-Boc-CPI (12; refs. 42 and 56)-alkylate the same sites in DNA. In addition to illustrating that the DNA alkylation reactions of (+)-and ent-(-)-11 are substantially less efficient (_ 104X) and less selective (selectivity = 5'-AA > 5'-TA) and proceed with an altered profile than (+)-or (-)-duocarmycin SA or CC-1065, the studies have shown that both enantiomers of 11 alkylate the same sites with essentially the same efficiency independent of the absolute stereochemistry (43) . Although these observations appear unusual, they are the natural consequence of the diastereomeric relationship of the adducts. The natural enantiomer binds in the 3' -> 5' direction from the site of alkylation extending over the adjacent 5' base. The unnatural enantiomer binds in the reverse 5' -> 3' orientation but with binding that also covers the same adjacent 5' base. These alkylation site models (42, 43) , which are illustrated in Fig. 2 , nicely accommodate the observed selectivity of 5'-AA > 5'-TA for both enantiomers. The preference of 5'-AA over 5'-TA (-2:1) is statistical rather than structural in nature since the complementary partner strand of a 5'-AT sequence contains an identical competitive alkylation site. The factor controlling alkylation is simply the depth of minor groove penetration accessible to the agent that is required to permit adenine-N3 alkylation of the electrophilic cyclopro- pane. For simple agents such as 11 and 12, this is possible only when the adjacent 5' base is A or T and models of an unobserved 5'-GA alkylation support this proposal (42, 43) . For 3 or 1, a larger 3.5-or 5-bp AT-rich site surrounding the alkylation site is required to permit sufficient groove penetration for alkylation and is further enhanced by the preferential noncovalent binding of the agents within the narrower, deeper AT-rich minor groove.
Reversibility of the DNA Alkylation Reaction: Binding-Driven Bonding. Although the duocarmycin DNA alkylations have proven similar to CC-1065, one important feature distinguishes the agents. Unlike (+)-CC-1065, which irreversibly alkylates DNA, (+)-duocarmycin SA and A were found to reversibly alkylate DNA (43, 47) . The ease of reversibility proved dependent upon the relative reactivity of the agent and the stability of the adduct as well as the extent of the noncovalent binding interactions. Consistent with the relative reactivity of the agents and the expected stability of the adducts, the (+)-duocarmycin A retroalkylation reaction was found to be slower than that of (+)-duocarmycin SA. In addition, a faster rate Thus, a dominant force stabilizing the DNA alkylation reaction is not only the covalent bond but also the noncovalent binding derived from hydrophobic binding and van der Waals contacts. That is, the reversible nature of the alkylation reaction is rendered less reversible or irreversible by noncovalent binding stabilization. The importance of these observations becomes clear in the comparison of the properties of the agents. The exceptionally potent cytotoxic activity of the natural products versus the relatively nonpotent activity of the simple derivatives including 11 and 12 may be attributed in part to the simple event of noncovalent binding stabilization of the inherently reversible DNA alkylation reaction.
Noncovalent Binding Affinity and Selectivity. Important insights into the struc- tural origin of the sequence-selective DNA alkylation were derived from examination of the binding affinity and selectivity of 13-16, key partial structures of 1-3 that were not capable of the subsequent covalent bond formation (61) (62) (63) (64) (65) (66) . Both relative and absolute DNA binding constants have been established and the agents were found to exhibit a substantial AT-rich minor groove binding selectivity (63, 64) . In addition, CDPI3 was found to be the optimum binding agent within the CDPI, series. The minor groove binding of CDPI3 spans 5 bp or one-half a helix turn, which constitutes the largest site accessible for synchronous binding of both ends of the rigid agent. Partial bound forms of the larger agents-i.e., CDPI2-bound CDPI4-were determined to constitute stable noncovalent complexes. The removal of the hydroxy and methoxy substituents (PDE-I1 -> CDPI,,) had only a small impact on the binding affinity and no apparent impact on the AT-rich binding selectivity (63) .
Consequently, the studies suggested that (+)-CC-1065 is best represented as a selective alkylating group superimposed upon the rigid CDPI3 skeleton (63) rather than as a reactive alkylating agent (CPI) attached to a DNA binding agent (PDE-12). The agents exhibit a substantial preference for noncovalent AT-rich minor groove binding that is optimal with the rigid trimer (CDPI3/PDE-13). Among features that contribute to minor groove binding selectivity, two structural characteristics of an A-T base pair and of a run of A-T base pairs may prove important to agents that rely on stabilizing van der Waals contacts and hydrophobic binding. First, a G-C base pair possesses an amino substituent that extends into the minor groove and a comparable substituent is not present on an A-T base pair. This sterically more accessible region adjacent to an A-T base pair permits the deeper penetration of an agent into the minor groove and enhances the stabilization derived from van der Waals contacts. In addition, x-ray crystallographic studies of oligodeoxynucleotides that contain central to their structure a run of A-T base pairs revealed characteristic features including the constricted width of the ATrich minor groove (13, 14) . This narrower AT-rich minor groove within DNA contributes prominently to the noncovalent binding selectivity of the agents that depend on stabilizing van der Waals contacts.
More recently, the DNA binding properties ofACDPIn (15; n = 1-4) and TACDPIn 1NMe3 -7.6 -9.8 -t 1 .1I the natural enantiomers has been attributed to a sequence-dependent activation through C4 carbonyl protonation by a strategically positioned phosphate in the DNA backbone (35-38, 55, 56) , the conformational variability of DNA and alkylation at junctions of bent DNA (67) (68) (69) , or preferential noncovalent binding and subsequent alkylation within the narrower, deeper minor groove of AT-rich DNA (27) (28) (29) (30) (31) (32) (33) (34) . Central to the interpretations are the perceived similarities (35) (36) (37) (38) (39) (53) (54) (55) (56) or distinctions (27-34, 42, 43) in the alkylation selectivity of simple derivatives including 11-12 and the natural products 1-3. The former two proposals are based on the premise that (+)-12 and (+)-1 alkylate the same DNA sites and that the alkylation subunit or alkylation reaction controls the selectivity irrespective of noncovalent binding. In contrast, the latter proposal requires that the AT-rich noncovalent binding selectivity of the agents and their steric accessibility to the alkylation site that accompanies deep penetration into the AT-rich minor groove control the sequence selectivity. Notably, this latter model accommodates nicely the reverse and offset 3.5-or 5-bp AT-rich adenine-N3 alkylation selectivities of the natural and unnatural enantiomers of 3 and 1, respectively, and requires that [11] [12] and 1-3 exhibit distinct alkylation selectivities (42, 43, 58) . In the first key study (59, 70, 71) , it was shown that 17-20 exhibited identical alkylation selectivities (5'-AA > 5'-TA) independent of their absolute configuration and identical to both enantiomers of 11 and 12. In addition, the natural enantiomers of [21] [22] [23] [24] exhibited DNA alkylation selectivities identical to that of (+)-CC-1065 and were more selective and more efficient than [17] [18] [19] [20] ,.-OMs (43) . One unique feature of 3 is the C6 methyl ester on the left-hand side of the alkylation subunit that complements the right-hand side linking amide. This feature provides the ability to introduce DNA binding subunits on either side of the duocarmycin SA alkylation subunit. In the studies, both the natural and unnatural enantiomers of the extended and reversed duocarmycin SA analogs 25 and 26 were examined.
Both (+)-DSA-CDPI2 and ent-(-)-DSA-CDPI2 (25) were found to alkylate DNA with the same selectivity as (+)-and ent-(-)-CC-1065 (1), respectively. The natural enantiomer of the reversed agent (+)-CDPI2-DSA (26) was found to alkylate DNA with the same selectivity as ent-(-)-DSA-CDPI2 and ent-(-)-CC-1065 (72) . This incorporation and conversion of a natural enantiomer of the duocarmycin SA alkylation subunit into an agent that exhibits the DNA alkylation selectivity of a typical unnatural enantiomer by simple reversal of the orientation of the DNA binding subunits of the agent are only consistent with a model where the AT-rich noncovalent binding selectivity and depth of minor groove penetration surrounding the alkylation site are controlling the sites of alkylation. Moreover, the observations are inconsistent with alternative models based on the premise that the natural enantiomer alkylation subunit controls the alkylation selectivity. Similarly, the unnatural enantiomer of the reversed agent ent-(-)-CDPI2-DSA (26) was found to alkylate the same sites as (+)-DSA-CDPI2 (25) [77] [78] [79] , and the extensive number of investigations directed at the subunits of the natural products (33) , studies that have provided analogs (80, 81) and agents containing deepseated structural modifications have proven unusually valuable in defining the relationships between structure, functional reactivity, and biological properties (82) (83) (84) (85) (86) (87) (88) (89) (90) (91) (92) (93) (94) (95) (96) (97) . The acid-catalyzed activation of the DNA alkylation reaction led to the intuitive proposal that there may exist a direct relationship between the reactivity and cytotoxic activity of the agents and established the expectation that the biological potency may be enhanced as the electrophilic reactivity is increased (81) . However, studies conducted with the agents 27-32, which were prepared by synthesis employing technology developed in the natural product total syntheses, revealed the reverse relationship and that the agents possessing the greatest stability may be expected to exhibit the most potent cytotoxic activity. Moreover, a well-defined direct relationship between solvolysis stability (pH 3) and biological (42, 43, 60) , the structural origins of the unusual stability of the natural alkylation subunits (94), the stereoelectronic control that dictates nucleophilic addition to the least substituted cyclopropane carbon (94) , subtle structural features that can modulate reactivity of the alkylation subunits (94, 95) , the SN2 versus SN1 mechanism of cyclopropane ring opening (94) , and extensions of the studies to rationally designed DNA crosslinking agents (96, 97) and prodrugs. Future studies with additional structural analogs of CC-1065 and the duocarmycins will continue to provide further insights into the origin of their properties. No doubt this will continue to lead to rationally designed synthetic agents whose properties overcome inherent limitations of the natural products themselves and further define subtle relationships between their structure, functional reactivity, and biological properties.
